SANTA MONICA, Calif. - GoodRx (NASDAQ: GDRX), a leading U.S. prescription savings platform, has announced that QSYMIA® is now available at over 70,000 retail pharmacy locations for a cash price of ...

GoodRx (NASDAQ: GDRX), a leading U.S. prescription savings platform, has announced that QSYMIA® is now available at over 70,000 retail pharmacy locations for a cash price of $149, exclusively ...

Now, anyone with a valid prescription, regardless of insurance status, can use GoodRx to purchase a 30-day supply of QSYMIA at the exclusive cash price of $149. QSYMIA is designed to help patients ...

GoodRx (GDRX) announced that Qsymia is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via GoodRx. This initiative not only propels GoodRx’s ...

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules CIV) is available for a low cash ...